When sourcing peptides for in vitro research, purity percentage is the single most important specification on a Certificate of Analysis. Yet many researchers accept this number without understanding what it actually measures, how it’s determined, or why the difference between 95% and 99% matters more than it might appear.
What HPLC Purity Actually Measures
High-performance liquid chromatography (HPLC) separates a sample’s components by passing them through a stationary phase under high pressure. Each component moves at a different rate depending on its interaction with the stationary phase, producing a chromatogram — a graph of detector response over time.
Purity is calculated as the area of the target compound’s peak divided by the total area of all peaks. A 99% HPLC purity reading means 99% of the UV-absorbing material in the sample is the target peptide; 1% is everything else — truncated sequences, deletion products, oxidized forms, residual solvents, or other synthesis byproducts.
This is an important distinction: HPLC measures UV-absorbing material, not absolute mass. Components that don’t absorb UV (e.g., water, some solvents) are not captured in the purity calculation. This is why a supplier that omits a mass-spec (LC-MS) confirmation alongside the HPLC report is providing an incomplete picture.
Why 99% vs. 95% Is Not a Small Difference
Consider a 5mg vial of BPC-157. At 95% purity, 0.25mg of the vial’s content is non-target material. At 99% purity, that drops to 0.05mg. When you reconstitute this vial and run an assay, those impurities are present in every well plate, every dose, every data point.
Peptide impurities are often truncated sequences — fragments of the target compound missing one or more amino acids. These fragments may:
- Bind the same receptor at a different affinity, confounding dose-response curves
- Act as competitive antagonists, suppressing the activity you’re trying to measure
- Trigger off-target biological effects that appear as false positives
- Reduce the effective molarity of your target compound, requiring recalculation of concentration
For pharmacological or receptor-binding studies, these are not theoretical concerns. They are reproducibility risks that compound across experiments and become publication-threatening when results can’t be replicated by another lab that sourced from a different supplier.
The Role of Mass Spectrometry
HPLC tells you how pure the material is; LC-MS tells you what the material actually is. A compound with high HPLC purity but no mass confirmation could theoretically be a highly pure version of the wrong compound — incorrect synthesis, substitution error, or mislabeling.
For this reason, responsible suppliers provide both a purity measurement (HPLC) and an identity confirmation (LC-MS or MALDI-TOF) on every COA. The mass spectrum should show a dominant peak at or near the theoretical molecular weight of the compound, calculated from its amino acid sequence and any modifications.
Evaluating a COA: What to Look For
| Parameter | Acceptable | Flag |
|---|---|---|
| HPLC purity | ≥99% | <98%, or “≥95%” claimed |
| Mass confirmation | LC-MS or MALDI provided | HPLC only, no mass spec |
| Batch code | Unique batch ID on report | Generic or missing |
| Testing lab | Named third party | In-house, unnamed, or “QC dept” |
| Analysis date | Within 12 months | Missing or >2 years old |
Setting a Minimum Standard for Your Lab
Establishing a formal sourcing policy for your lab or institution reduces the risk of purity-related variability across experiments. A practical minimum standard for research-grade peptides:
- HPLC purity ≥99% (reverse-phase)
- LC-MS mass confirmation provided
- COA from a named independent laboratory
- Batch-specific (not lot-generic) documentation
- Analysis date within 18 months of shipment
Suppliers that meet these criteria represent a small subset of the market. Price differences between ≥99% and ≥95% product are typically minor relative to the time cost of debugging a failed assay or repeating an experiment after discovering purity issues post-publication.
This article is for informational purposes for qualified researchers. All peptides sold by Bastion Peptides LLC are intended for in vitro research and laboratory use only. Not for human or animal consumption. Not approved by the FDA for therapeutic use.
